师资队伍

何勇
职称:主任药师
领域:临床药学
联系电话:0851-27596153
电子邮箱:heyongzmu@163.com
办公室(实验室):临床药学教研室

 

二附院药剂科科主任,党支部书记、GCP办公室副主任,博士生导师,主任药师,博士

中国药理学会治疗药物监测研究专业委员会委员;中国医药教育协会抗肿瘤用药研究与评价分会常委;中国药理学会药物代谢专业委员会青年委员.

贵州省千层次创新型人才;贵州省药品注册审批专家;贵州省药理学会理事;贵州省药学会理事;贵州省药学会药物分析专业委员会副主任委员;贵州省药学会临床药学专业委员会副主任委员;贵州省药学会妇产科疾病治疗专业委员会副主任委员;贵州省医学会临床药学委员会常委;贵州省药学会药学服务专业委员会常委;贵州省医院协会药事管理专委会常委;贵州省药学会第四届医院药学专业委员会委员。

主持国家自然科学基金、国家卫健委、省科技厅重点项目等项目8项;承担国家药品监督管理局“十四五”规划前期重大研究课题2项;编制贵州省省级“十四五”规划1项。

Biosens Bioelectron, ACS Sens, Anal Chem, Anal Chim Acta, Sens Actuators, B, Microchimica Acta等发表SCI论文22篇(2IF>1016IF>5),累计影响因子143

教育经历:

20159-20186  西南大学药学院 生物药物分析 博士

20069-20096  遵义医科大学  药理学 硕士

20009-20046  西南大学生命科学学院 制药工程 学士

工作经历:

20224-至今  遵义医科大学第二附属医院药剂科 科主任

20047-20224  遵义医科大学附属医院药剂科

(期间:20207-20224  遵义医科大学附属医院药剂科

20198-20207  国家药监局综合司

20059-20162  中国药科大进修)

 

(一)基础研究:主要集中在纳米酶在治疗药物监测及时检测方面研究

1.课题情况

《抗肿瘤药物TDM 检测试剂盒和生物传感产品关键技术研究》(在研)

《新型纳米酶的制备及其在治疗药物监测应用的基础研究》(NSFC申请项目)

2.指导研究生发表论文情况

※Wu Lulu, Yang Fei, Ma Yuchan, Tang Li, Liu Hongmei, Wang Wenwen, Ouyang Hui, Fu Zhifeng*, He Yong*. Valve-controlled needle-type “mix and detect” integrated distance-based sensor with visual color zoning for point-of-care detection of tacrolimus. Biosens Bioelectron 1区,10.7,返修)

Wu LuLu, Zhu Zhongjie, Xue Jinxia, Zheng Liang, Liu Hongmei, Ouyang Hui, Fu Zhifeng*, He Yong*. Chemiluminescent/photothermal dual-mode lateral flow immunoassay based on CoFe PBAs/WS2 nanozyme for rapid and highly sensitive point-of-care testing of gentamicin. Biosens Bioelectron 2024, 265, 116711.1区,10.7

Zhu Zhongjie, Zhang Yu, Xue Jinxia, Kong Jing, Huang Ling, Ouyang Hui, Fu Zhifeng*, He Yong*. Fluorescent immunochromatographic test strip for therapeutic drug monitoring of methotrexate with high sensitivity and wide dynamic range. Microchimica Acta, 2023, 190:342. (2, IF 5.7)

(二)药事管理研究:主要集中在横断面研究和中断时间序列研究

1.课题情况

1)《第二批国家重点监控药品量化指标体系研究:一项多中心横断面研究》(在研)

2)《DDDs影响因素及变异性研究》(在研)

2.指导研究生发表论文情况

Tang Li, Liu Hongmei, Wu Shasha, Liu Jing, Jiang Xiaoyu, Fu Yuanyuan, Tao Na*, He Yong*. A point prevalence survey and monitoring indicators research on 2nd batch of national key monitoring and rational use drugs. Front Pharmacol 2024, 15, 1416010. (2区,IF 4.4)

(三)观察性临床研究:

指导研究生发表论文情况

※ Liu Hongmei, Tang Li, Zheng Liang, Fu Yuanyuan, Qian Mingjiang, Ouyang Canghong, Tao Na, Ou Shuiping, He Yong*. Colistin sulfate versus polymyxin B for the treatment of infections caused by carbapenem-resistant Acinetobacter baumannii: A multicenter retrospective cohort study. Front Pharmacol 2区,4.4accepted

主持科研项目:

DDDs影响因素及变异性研究》,国家卫健委,合同编号:NIHAYS2437202501-202612

《第二批国家重点监控药品量化指标体系研究:一项多中心横断面研究》,贵州卫健委合同编号:gzwkj2025-548202501-202612

《抗肿瘤药物TDM 检测试剂盒和生物传感产品关键技术研究 省科技厅》,贵州省科技厅重点项目,合同编号:黔科合基础-zk[2024]重点0646202404-202803

贵州省千层次人才项目,贵州省卫健委,202401-202612

《基于噬菌体功能性蛋白识别的抗菌药物敏感性试验新方法》,国家自然科学基金,合同编号:21964023202001-202312

《基于噬菌体尾丝蛋白识别的侧向层析技术检测细菌的新方法》,贵州省科技厅,合同编号:黔科合基础[2020]1Y044202001-202212

《铜绿假单胞菌噬菌体PAP1功能性蛋白的重组表达及应用》,博士启动基金,[2018]05号,201901-202112

《医院药学高层次人才引进培养面临的问题及对策研究》,贵州省委组织部,201901-202012

(一)通讯作者或第一作者

Wu LuLu, Zhu Zhongjie, Xue Jinxia, Zheng Liang, Liu Hongmei, Ouyang Hui, Fu Zhifeng*, He Yong*. Chemiluminescent/photothermal dual-mode lateral flow immunoassay based on CoFe PBAs/WS2 nanozyme for rapid and highly sensitive point-of-care testing of gentamicin. Biosens Bioelectron 2024, 265, 116711. 1 IF 10.7

Tang Li, Liu Hongmei, Wu Shasha, Liu Jing, Jiang Xiaoyu, Fu Yuanyuan, Tao Na*, He Yong*. A point prevalence survey and monitoring indicator research on the second batch of national key monitoring and rational use drugs. Front Pharmacol 2024, 15, 1416010.2 IF 4.4

Zhu Zhongjie, Zhang Yu, Xue Jinxia, Kong Jing, Huang Ling, Ouyang Hui, Fu Zhifeng*, He Yong*. Fluorescent immunochromatographic test strip for therapeutic drug monitoring of methotrexate with high sensitivity and wide dynamic range. Microchimica Acta, 2023, 190:342. (2, IF 5.7)

Ma Yuchan, Zhang Yu, Gao Jiaqi, Ouyang Hui, He Yong*, Fu Zhifeng*. PEGylated Ni single-atom catalysts as ultrasensitive electrochemiluminescent probes with favorable aqueous dispersibility for assaying drug-resistant pathogens. Anal. Chem. 2022, 94, 14047-14053. (1 IF 8.008)

Li Jizhou, Xue Jinxia, Zhang Yu, He Yong*, Fu Zhifeng*. Shape-encoded functional hydrogel pellets for multiplexed detection of pathogenic bacteria using a gas pressure sensor. ACS Sens. 2022, 7, 2438-2445. (1 IF 9.168)

Zhang Yu, Li Jizhou, Ma Yuchan, He Yong*, Fu Zhifeng*. Small ubiquitin-related modifier-fused bacteriophage tail fiber protein with favorable aqueous solubility for lateral flow assay of Pseudomonas aeruginosa. Biosens. Bioelectron. 2022, 216, 114637. (1 IF 12.545)

He Yong, Zhao Hang, Liu Yuanwen, Zhou He*. Specific and rapid reverse assaying protocol for detection and antimicrobial susceptibility testing of Pseudomonas aeruginosa based on dual molecular recognition. Sci. Rep. 2021, 11, 11101. (3IF 4.38)

Shi Yanli, He Yong(共同一作), Zhang Lvxia, Wang Lin, Fu Zhifeng*. Dual-site recognition of Pseudomonas aeruginosa using polymyxin B and bacteriophage tail fiber protein. Anal. Chim. Acta 2021, 1180, 338855. (1IF 6.56)

He Yong, Shi Yanli, Liu Mengli, Wang Yingran, Wang Ling, Lu Shuguang*, Fu Zhifeng*. Nonlytic recombinant phage tail fiber protein for specific recognition of Pseudomonas aeruginosa. Anal. Chem. 2018, 90, 14462-14468. (1 IF 6.35)

He Yong, Wang Yingran, Shi Yanli, Fu Zhifeng*. Molecular recognition strategy for detection and antimicrobial susceptibility testing of Staphylococcus aureus by utilizing teicoplanin and porcine IgG as indicator molecules. Sens. Actuators, B. 2018, 267, 51-57. (1 IF 6.39)

He Yong, Fan Enci, Wang Mengyao, Lu Shuguang*, Fu Zhifeng*. Antimicrobial susceptibility testing by using virulent phages to evaluate bacterial viability. Anal. Methods 2018, 10, 1799-1804. (3 IF 2.07)

He Yong, Wang Mengyao, Fan Enci, Ouyang Hui, Yue Huan, Su Xiaoxiao, Liao Guojian, Wang Ling, Lu Shuguang*, Fu Zhifeng*. Highly specific bacteriophage-affinity strategy for rapid separation and sensitive detection of viable Pseudomonas aeruginosa. Anal. Chem. 2017, 89, 1916-1921. (1 IF 6.04)

(二)合作

Zhou Yali, Wang Pingshi, Xiong Jie, Yue Huan, He Yong, Ouyang Hui, Wang Lin, Fu Zhifeng*. A label-free strategy for measuring the affinity between monoclonal antibody and hapten using microdialysis sampling combined with chemiluminescent detection. Biosens. Bioelectron. 2017, 87, 404-409. (1IF 8.17)

Su Xiaoxiao, Wang Mengyao, Ouyang Hui, Yang Shijia, Wang Wenwen, He Yong, Fu Zhifeng*. Bioluminescent detection of the total amount of viable Gram-positivebacteria isolated by vancomycin-functionalized magnetic particles. Sens. Actuators, B 2017, 241, 255-261. (1IF 5.67)

Wang Mengyao, Wu Yue, He Yong, Su Xiaoxiao, Ouyang Hui, Fu Zhifeng*. Antibiotic-affinity strategy for bioluminescent detection of viable Gram-positive bacteria using daptomycin as recognition agent. Anal. Chim. Acta 2017, 987, 91-97. (1IF 5.12)

Yue Huan, He Yong, Fan Enci, Wang Lin, Lu Suguang, Fu Zhifeng*. Label-free electrochemiluminescent biosensor for rapid and sensitive detection of Pseudomonas aeruginosa using phage as highly specific recognition agent. Biosens. Bioelectron. 2017, 94, 429-432. (1IF 8.17)

Wu Yue, Wang Mengyao, Ouyang Hui, He Yong, Zhao Xiaoyan, Fu Zhifeng*. Teicoplanin-functionalized magnetic beads for detection of Staphylococcus aureus via inhibition of the luminol chemiluminescence by intracellular catalase. Microchim. Acta 2018, 185, 8. (2IF 5.70)

Wang Zhenxing, Ouyang Hui, Tesauro Cinzia, Ottaviani Alessio, He Yong, Fiorani Paola, Xie Hui, Desideri Alessandro, Fu Zhifeng*. Real-time analysis of cleavage and religation activity of human topoisomerase 1 based on ternary fluorescence resonance energy transfer DNA substrate. Arch. Biochem. Biophys. 2018, 643, 1-6. (3IF 3.12)

Su Xiaoxiao, Wang Mengyao, Wu Yue, He Yong, Fu Zhifeng*. Specific chemiluminescent protocol for dual-site recognition of Streptococcus mutans utilizing strong affinity between teicoplanin and Gram-positive bacteria. Talanta 2018, 179, 350-355. (2IF 4.91)

※ Fan Enci, Peng Jinxiu, He Yong, Wu Yue, Ouyang Hui, Xu Zhaoqing, Fu Zhifeng*. Chemiluminescent analysis of Staphylococcus aureus utilizing phe(11)-protonectin against Gram-positive bacteria. Sens. Actuators, B. 2019, 285, 271-276. (1 IF 7.1)

Shi Yanli, Yang Honglin, He Yong, Fu Zhifeng*. Antibiotic-affinity chromatographic test strip for quantitative analysis and antibiotic resistance testing of Staphylococcus aureus. Talanta 2019, 205, 120130. (2IF 5.34)

Wang Yingran, He Yong, Bhattacharyya Sanjib, Lu Suguang, Fu Zhifeng*. Recombinant Bacteriophage Cell-Binding Domain Proteins for Broad-Spectrum Recognition of Methicillin-Resistant Staphylococcus aureus Strains. Anal. Chem. 2020, 92, 3340-3345. (1 IF 6.79)

地址:贵州省遵义市新蒲新区校园1号路(新蒲校区)  版权所有©遵义医科大学药学院  黔ICP备06003261号-2